AGONISTE DES RÉCEPTEURS AUX HYDROCARBURES AROMATIQUES DESTINÉ À ÊTRE UTILISÉ DANS UN TRAITEMENT D'ASSOCIATION CONTRE LE CANCER

摘要

The present invention relates to an AhR agonist for use in combination with at least one immune checkpoint modulator in the treatment of cancer. The present invention also encompasses product containing an AhR agonist and at least one immune checkpoint modulator as defined in any one of the preceding claims, as a combined preparation for simultaneous, separate or sequential use in the treatment of cancer.